Mitoxantrone 2 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2 mg/mL

Reference Brands: Novantrone (USA)

Category: Oncology Cancer Care

Mitoxantrone (brand name Novantrone® and generics) is an antineoplastic (chemotherapy) medication used to treat certain cancers like acute nonlymphocytic leukemia (ANLL), advanced prostate cancer, and selected multiple sclerosis (MS) cases by slowing down abnormal cell growth and suppressing an overactive immune system. It is delivered as an intravenous infusion in a clinical setting.

Product Description:

Mitoxantrone hydrochloride is an antineoplastic chemotherapy medication widely used in Oncology Cancer Care for treating various malignant conditions. It is most commonly prescribed for acute non-lymphocytic leukemia, advanced hormone-refractory prostate cancer, and selected severe cases of multiple sclerosis where other therapies have not been effective. Mitoxantrone works by binding to DNA and inhibiting topoisomerase II, an essential enzyme involved in DNA replication and repair. This action disrupts the growth and division of rapidly multiplying cancer cells, ultimately leading to their destruction. The drug is administered strictly by intravenous infusion under medical supervision, ensuring controlled dosing and monitoring for potential side effects. In oncology settings, mitoxantrone is often used in combination with other chemotherapeutic agents to increase treatment effectiveness. It is known for its deep blue coloration and is typically supplied as a 2 mg/mL injection solution in single-dose or multi-dose vials. While effective, mitoxantrone requires careful monitoring due to the risk of cardiotoxicity, bone marrow suppression, and cumulative dose limitations. Despite these considerations, it remains an important treatment option in modern cancer therapy and is widely used in many global treatment protocols.